Antibodies, Monoclonal, Murine-Derived
Antineoplastic Combined Chemotherapy Protocols
Combined Modality Therapy
Cyclophosphamide
Disease-Free Survival
Focal Adhesion Kinase 1
Gene Expression
Humans
Immunotherapy
Leukemia, Lymphocytic, Chronic, B-Cell
Proportional Hazards Models
RNA, Messenger
RNA, Neoplasm
Recurrence
Retrospective Studies
Vidarabine
